Navigation Links
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
Date:12/26/2013

LA JOLLA, Calif., December 26, 2013 Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cellsmacrophagesare stimulated in response to pathogens. The molecule, termed "THRIL," helps regulate the immune response and shows an association with Kawasaki disease. The findings suggest that THRIL may contribute to other inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The study, published online in Proceedings of the National Academy of Sciences, measured large intergenic noncoding RNA (lincRNA) produced when the immune system is activated. One lincRNA was found to bind heterogenous nuclear ribonucleoprotein L (hnRNPL), creating a new molecule that regulates genetic control of TNF-alphaa potent cytokine that promotes inflammation. The authors named the molecule THRIL, after TNF-alpha and hnRNPL-related immunoregulatory lincRNA.

Noncoding RNAs as key regulators of immune response

Large noncoding RNA corresponds to the parts of the genome that do not code for protein.

"For some time we have known that noncoding regions of RNA play important roles in regulating the immune response to microbial pathogens," said Tariq Rana, Ph.D., senior author of the study and professor in the Sanford Children's Health Research Center and director of the RNA Biology Program at Sanford-Burnham. "When we realized that THRIL functioned to control the TNF-alpha gene, we wanted to see if it mirrors the progression in inflammatory diseases."

Collaborating with Jane Burns, M.D., professor of pediatrics at Rady Children's Hospital and UC San Diego, Rana's team measured THRIL levels in Kawasaki disease samples at different stages of the disease, and found that levels were at their lowest during the acute stage of the diseasewhen TNF-alpha levels are at their highest.

The findings suggest that THRIL could be a novel biomarker for immune activation and a potential target for inflammatory diseases.


'/>"/>

Contact: Susan Gammon
858-795-5012
Sanford-Burnham Medical Research Institute
Source:Eurekalert  

Related biology news :

1. The next era in discovering drugs in natures own medicine cabinet
2. Researchers develop tools for discovering new species
3. Discovering cell surface proteins behavior
4. Protein explains increased asthma severity in children exposed to diesel exhaust from traffic
5. Small protein plays big role in asthma severity
6. Probiotic bacterium lessens severity of Salmonella infections by hoarding iron
7. CSHL geneticists solve mystery of EEC Syndromes variable severity in children
8. Gut microbes could determine the severity of melamine-induced kidney disease
9. Researchers show prebiotic can reduce severity of colitis
10. Exposure to antibiotics linked to severity of allergic asthma: UBC research
11. Gene therapy for human skin disease produces long-term benefits
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Discovering a 'THRIL' that correlates with severity of Kawasaki disease
(Date:2/1/2016)... Feb. 1, 2016  Today, the first day of ... plans to develop a first of its kind workplace ... IBM Watson. In the first application of ... IBM ), and Welltok will create a new ... with cognitive analytics, delivered on Welltok,s health optimization platform. ...
(Date:1/25/2016)... Jan. 25, 2016  Glencoe Software, the world-leading supplier ... publication industries, will provide the data management solution OMERO ... Photo ... Phenotypic analysis measures the characteristics ... allowing comparisons between states such as health and disease, ...
(Date:1/20/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce the attainment of ... the result of the company,s laser focus on (and ... , it,s comprehensive, easy-to-use and highly affordable cloud-based technology ... Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... , ... February 11, 2016 ... ... publication dedicated to delivering cutting-edge information focused on the development and manufacture ... to become a premier sponsor of the 2016 BioProcess International Awards – ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... more than 150 years, continues today to pursue the highest level of accuracy ... analytical instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and ...
(Date:2/10/2016)... Early-career researchers from ... , Uganda and Yemen ... nutrition   Indonesia , Nepal ... Yemen are being honored for their accomplishments in ... celebrated for mentoring young women scientists who are pursuing careers in agriculture, ...
(Date:2/10/2016)... Tarrytown, New York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that ... discover and develop new vaccines and immunotherapies for infectious diseases and cancer. ...
Breaking Biology Technology: